Table 1 Demographics and clinical data of all eyes and by group
All | Group A | Group B | P value | |
|---|---|---|---|---|
Number of eyes | 26 | 14 | 12 | |
Gender, male/female | 8/18 (30.7%) | 4/14 (28.6%) | 4/12 (33.3%) | 1.000 |
Age, years | 51.0 (11.6) | 53.9 (11.3) | 47.8 (11.6) | 0.187 |
Number of injections | 2.5 (1.8) | 3.1 (2.2) | 1.8 (0.8) | 0.075 |
Baseline logMAR BCVA, letters | 0.64 (0.23) | 0.64 (0.22) | 0.62 (0.25) | 0.918 |
Baseline SE, D | -13.82 (5.24) | -14.01 (5.26) | -13.61 (5.47) | 0.853 |
Baseline AL, mm | 30.3 (0.9) | 30.1 (0.5) | 30.5 (1.0) | 0.402 |
pCRA area, mm2 | 0.88 (1.69) | 1.27 (2.14) | 0.41 (0.79) | 0.201 |
Perilesional pCRA | 0.42 (1.38) | 0.69 (1.85) | 0.10 (0.33) | 0.283 |
Patchy Extralesional pCRA | 0.46 (1.00) | 0.58 (1.18) | 0.32 (0.77) | 0.512 |
Follow up, months | 23.2 (9.6) | 22.7 (11.7) | 23.9 (6.7) | 0.757 |